Results 121 to 130 of about 26,959 (237)

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study

Structural Heart
Background: The ALLEGRA (Biosensors International) transcatheter heart valve is a self-expanding supra-annular bovine pericardial aortic valve. A new delivery system (IMPERIA™, Biosensors International) has been designed which allows the valve to be ...
José Antonio Baz, MD, Christof Burgdorf, MD, Christian Frerker, MD, Ignacio Cruz González, MD, Joan Antoni Gômez, MD, Joseph Graham, MD, José Maria Hernândez, MD, Pilar Jimenez, MD, Claire B. Ren, MD, Ernest Spitzer, MD, Pim Tonino, MD, Pieter Vriesendorp, MD, Nicolas van Mieghem, MD, Samuel Copt, PhD, Anders Jönsson, MD, Keith G. Oldroyd, MD, Nicolas Doll, MD   +16 more
doaj   +1 more source

Transcatheter aortic valve-in-valve implantation for failed aortic bioprosthesis

Revista Portuguesa de Cardiologia (English Edition), 2012
Percutaneous valve replacement for severe aortic stenosis has been shown to be an alternative treatment option for high surgical risk patients. We describe our first valve-in-valve procedure in a patient with a degenerated aortic bioprosthesis and severe regurgitation.
Olga, Sousa, Eulália, Pereira, Daniel, Caeiro, José, Ribeiro, João, Primo, Pedro, Braga, Luís, Vouga, Vasco, Gama   +7 more
openaire   +2 more sources

Real‐World Comparison of Vascular Access Closure Strategies in TAVI

Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2150-2152, June 1, 2026.
Saif Zako, Kathrin Klein, Karin Alde, Christian Jung, Verena Veulemanns, Maximilian Scherner, Artur Lichtenberg, Malte Kelm, Tobias Zeus, Amin Polzin   +9 more
wiley   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Sheathless Transcaval Transcatheter Aortic Valve Implantation Through an Abdominal Aortic Graft.

, 2018
An 82-year-old patient presented with severe symptomatic aortic stenosis, a high surgical risk profile, and a history of abdominal aortic replacement. Arterial access vessel conditions precluded transarterial transcatheter aortic valve implantation (TAVI)
Lederman, Robert J, Lanz, Jonas, Windecker, Stephan, Pilgrim, Thomas, Greenbaum, Adam B   +4 more
core   +1 more source

Left ventricular guidewire pacing for transcatheter aortic valve implantation

, 2012
Previous reports prove the safety and efficacy of cardiac pacing employing a guidewire in the left ventricle as unipolar pacing electrode. We describe the use of left ventricular guidewire pacing as an alternative to conventional transvenous temporary ...
Wenaweser, Peter, Guérios, Enio E, Meier, Bernhard   +2 more
core   +1 more source

Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients.

, 2017
PURPOSE OF REVIEW The goal of this review is to summarize the current evidence supporting the use of transcatheter aortic valve implantation (TAVI) in high and intermediate-risk patients. The focus is on the five randomized controlled trials comparing
Windecker, Stephan, Siontis, George C M, Praz, Fabien, Jüni, Peter, Verma, Subodh   +4 more
core   +1 more source

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

, 2012
Transcatheter aortic valve implantation (TAVI) has emerged as a treatment alternative to surgical aortic valve replacement in elderly high-risk patients with symptomatic severe aortic stenosis. In this patient population, rapid improvement or restoration
Windecker, Stephan, Buellesfeld, Lutz, Pilgrim, Thomas, Schmid, Valerie, Kadner, Alexander, Wenaweser, Peter, Stortecky, Stefan, Khattab, Ahmed A   +7 more
core   +1 more source

Spotlight on the SAPIEN 3 transcatheter heart valve

Medical Devices: Evidence and Research, 2018
Tobias Rheude,1 Johannes Blumenstein,2 Helge Möllmann,2 Oliver Husser2 1Department of Cardiovascular Diseases, German Heart Centre, Technical University Munich, Munich, Germany; 2Department of Cardiology, St.-Johannes-Hospital, Dortmund, Germany ...
Rheude T, Blumenstein J, Möllmann H, Husser O   +3 more
doaj  

Transcatheter aortic valve implantation: patient selection

, 2013
Transcatheter aortic valve implantation (TAVI) is a disruptive technology as it satisfies a previously unmet need which is associated with a profound therapeutic benefit.
Windecker, Stephan, O'Sullivan, Crochan John, Wenaweser, Peter Martin, Stortecky, Stefan, Büllesfeld, Lutz   +4 more
core